Table of Contents

Oncology

• Clinical

  • 

    You have access

    Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma

    Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger and Wolfgang P. Fendler

    Journal of Nuclear Medicine June 1, 2022, 63 (6) 869-874; DOI: https://doi.org/10.2967/jnumed.121.262797
  • 

    Open Access

    The Added Value of ⁶⁸Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with ¹⁸F-FDG–Negative Findings

    Bingxin Gu, Xiaoping Xu, Ji Zhang, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song

    Journal of Nuclear Medicine June 1, 2022, 63 (6) 875-881; DOI: https://doi.org/10.2967/jnumed.121.262790
  • 

    You have access

    Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After ⁹⁰Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity

    Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo and Yuni K. Dewaraja

    Journal of Nuclear Medicine June 1, 2022, 63 (6) 882-889; DOI: https://doi.org/10.2967/jnumed.121.262447
  • 

    You have access

    Pitfalls and Common Findings in ⁶⁸Ga-FAPI PET: A Pictorial Analysis

    Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler

    Journal of Nuclear Medicine June 1, 2022, 63 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.121.262808

  • INVITED PERSPECTIVE

    • You have access

      Imaging PD-L1 Expression in Melanoma Brain Metastases

      Sridhar Nimmagadda

      Journal of Nuclear Medicine June 1, 2022, 63 (6) 897-898; DOI: https://doi.org/10.2967/jnumed.121.263209
  • 

    Open Access

    ¹⁸F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study

    Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers

    Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368
  • 

    You have access

    ¹⁸F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma

    Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh and Neeta Pandit-Taskar

    Journal of Nuclear Medicine June 1, 2022, 63 (6) 906-911; DOI: https://doi.org/10.2967/jnumed.121.262882

• Translational

  • 

    You have access

    Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma

    Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha and Manu Jain

    Journal of Nuclear Medicine June 1, 2022, 63 (6) 912-918; DOI: https://doi.org/10.2967/jnumed.121.262600